ARQT
Arcutis Biotherapeutics (ARQT) Investor Questions
Review Arcutis Biotherapeutics (ARQT) faq with company data, supporting context and links to related investor research.
Research record updated: . Individual measures may refer to different reporting periods.
- Company
- Arcutis Biotherapeutics
- Sector
- Healthcare
- Industry
- Biotechnology
- Overall BTI score
- 80
- Annual revenue
- $376.07M
- Annual net income
- $-16.14M
- Annual free cash flow
- $-6.31M
Arcutis Biotherapeutics (ARQT) Investor Questions research
Arcutis Biotherapeutics trades under the ticker ARQT. The company is classified in the Healthcare sector and the Biotechnology industry.
Investors commonly review ARQT through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. Use the financial statements to check whether reported profit is supported by cash generation.